Ultragenyx Pharmaceutical Inc.
RARE
Revenue
164.88M
▲25.38M▲18.20%
3 Months ChangeAssets
1.50B
▼-34.91M▼-2.27%
3 Months ChangeLiabilities
1.24B
▲56.62M▲4.78%
3 Months ChangeFree Cash Flow
-193.94M
▼-12.04M▼-6.62%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-07
Form 8-K
ID: 0000950170-24-113085
2024-10-03
Form 8-K
ID: 0000950170-24-112402
2024-08-02
Form 10-Q
ID: 0000950170-24-089488
2024-08-01
Form 8-K
ID: 0000950170-24-089263
2024-07-17
Form 8-K
ID: 0000950170-24-084254
2024-06-21
Form 8-K
ID: 0000950170-24-076222
2024-06-17
Form 8-K
ID: 0001193125-24-162003
2024-06-12
Form 8-K
ID: 0000950170-24-072414
2024-06-12
Form 8-K
ID: 0000950170-24-072119
2024-05-30
Form 8-K
ID: 0000950170-24-066553